Kala Y Kamdar (Kala Kamdar)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Acute Lymphoblastic Leukemia

Childhood Cancer

Top Venues

JCO precision oncology

Pharmacotherapy

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 43 (3) (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 43 (3) (2023)
Nader El-Mallawany Kim, Kala Y Kamdar
Evolving beyond morphology in pediatric PTLD. Blood 142 (5) (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy (2023)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 43 (3) (2023)
Melissa A Richard, Sogol Mostoufi-Moab, Nisha Rathore, Jessica L Baedke, Austin L Brown, Stephen J Chanock, Danielle Novetsky Friedman, Maria Monica J Gramatges, Rebecca M Howell, Kala Y Kamdar, Wendy M Leisenring, Lillian R Meacham, Lindsay M Morton, Kevin C Oeffinger, Leslie L Robison, Yadav Sapkota, Charles A Sklar, Gregory T Armstrong, Smita Bhatia, Philip J Lupo
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO precision oncology 6 (2022)
Melissa A Richard, Sogol Mostoufi-Moab, Nisha Rathore, Jessica L Baedke, Austin L Brown, Stephen J Chanock, Danielle Novetsky Friedman, Maria Monica J Gramatges, Rebecca M Howell, Kala Y Kamdar, Wendy M Leisenring, Lillian R Meacham, Lindsay M Morton, Kevin C Oeffinger, Leslie L Robison, Yadav Sapkota, Charles A Sklar, Gregory T Armstrong, Smita Bhatia, Philip J Lupo
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO precision oncology 6 (2022)
Melissa A Richard, Sogol Mostoufi-Moab, Nisha Rathore, Jessica L Baedke, Austin L Brown, Stephen J Chanock, Danielle Novetsky Friedman, Maria Monica J Gramatges, Rebecca M Howell, Kala Y Kamdar, Wendy M Leisenring, Lillian R Meacham, Lindsay M Morton, Kevin C Oeffinger, Leslie L Robison, Yadav Sapkota, Charles A Sklar, Gregory T Armstrong, Smita Bhatia, Philip J Lupo
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO precision oncology 6 (2022)
Melissa A Richard, Sogol Mostoufi-Moab, Nisha Rathore, Jessica L Baedke, Austin L Brown, Stephen J Chanock, Danielle Novetsky Friedman, Maria Monica J Gramatges, Rebecca M Howell, Kala Y Kamdar, Wendy M Leisenring, Lillian R Meacham, Lindsay M Morton, Kevin C Oeffinger, Leslie L Robison, Yadav Sapkota, Charles A Sklar, Gregory T Armstrong, Smita Bhatia, Philip J Lupo
Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO precision oncology 6 (2022)
Ankhi Dutta, Ashley Ikwuezunma, Maria I Castellanos, Julienne Brackett, Kiranmye Reddy, Priya Mahajan, Ann M Marshburn, Kala Y Kamdar, Hana Paek, Debra L Palazzi, Karen R Rabin, Michael E Scheurer, Maria Monica J Gramatges
An evidence-based, risk-adapted algorithm for antifungal prophylaxis reduces risk for invasive mold infections in children with hematologic malignancies. Pediatric blood & cancer 68 (12) (2021)
Mark C Zobeck, Melanie Brooke Bernhardt, Kala Y Kamdar, Karen R Rabin, Philip J Lupo, Michael E Scheurer
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatric blood & cancer 68 (8) (2021)